Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Haas

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2009
Oxidative stress mediates a reduced expression of the activating receptor NKG2D in NK cells from end-stage renal disease patientsMarie-Noëlle Peraldi, Jeannig Berrou, Nicolas Dulphy, et al.
Blood|September 30, 2009
MICA-129 genotype, soluble MICA, and anti-MICA antibodies as biomarkers of chronic graft-versus-host diseaseWahid Boukouaci, Marc Busson, Régis Peffault de Latour, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2008
An unusual CD56(bright) CD16(low) NK cell subset dominates the early posttransplant period following HLA-matched hematopoietic stem cell transplantationNicolas Dulphy, Philippe Haas, Marc Busson, et al.
Trials|February 5, 2022
High-dose vitamin D substitution in patients with COVID-19: study protocol for a randomized, double-blind, placebo-controlled, multi-center study-VitCov TrialFabienne Jaun, Maria Boesing, Giorgia Lüthi-Corridori, et al.
Haematologica|August 3, 2014
Favorable impact of natural killer cell reconstitution on chronic graft-versus-host disease and cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantationVissal David Kheav, Marc Busson, Catherine Scieux, et al.
Trials|September 20, 2022
Inhaled aviptadil for the possible treatment of COVID-19 in patients at high risk for ARDS: study protocol for a randomized, placebo-controlled, and multicenter trialMaria Boesing, Kristin Abig, Michael Brändle, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2009
Oxidative stress mediates a reduced expression of the activating receptor NKG2D in NK cells from end-stage renal disease patientsMarie-Noëlle Peraldi, Jeannig Berrou, Nicolas Dulphy, et al.
Blood|September 30, 2009
MICA-129 genotype, soluble MICA, and anti-MICA antibodies as biomarkers of chronic graft-versus-host diseaseWahid Boukouaci, Marc Busson, Régis Peffault de Latour, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2008
An unusual CD56(bright) CD16(low) NK cell subset dominates the early posttransplant period following HLA-matched hematopoietic stem cell transplantationNicolas Dulphy, Philippe Haas, Marc Busson, et al.
Trials|February 5, 2022
High-dose vitamin D substitution in patients with COVID-19: study protocol for a randomized, double-blind, placebo-controlled, multi-center study-VitCov TrialFabienne Jaun, Maria Boesing, Giorgia Lüthi-Corridori, et al.
Haematologica|August 3, 2014
Favorable impact of natural killer cell reconstitution on chronic graft-versus-host disease and cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantationVissal David Kheav, Marc Busson, Catherine Scieux, et al.
Trials|September 20, 2022
Inhaled aviptadil for the possible treatment of COVID-19 in patients at high risk for ARDS: study protocol for a randomized, placebo-controlled, and multicenter trialMaria Boesing, Kristin Abig, Michael Brändle, et al.
Pageof 2